title: Population-based study of the increased incidence of skin and soft tissue infections and associated antimicrobial use.
abstract: Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) has spread rapidly throughout the world in the last decade. We sought to demonstrate the impact of the emergence of CA-MRSA in Western Canada on physician visits, incision-and-drainage procedures, and antibiotic prescribing for skin and soft tissue infections (SSTI). We used the provincial physician billing system to determine the rate of physician visits (per 1,000 population per year) of SSTI and incision-and-drainage procedures. A database capturing all outpatient prescriptions in the province was anonymously linked to associated physician billing codes to quantify prescriptions associated with SSTI. Antibiotic prescriptions (overall and class specific) were expressed as their defined daily dose (DDD) per 1,000 inhabitants per day. Between 1996 and 2008, the rate of visits for all SSTI increased by 15%, and the majority of visits did not include an incision-and-drainage procedure. The rate of antibiotic prescribing for SSTI increased by 49%. The majority of this increase was attributable to the higher rates of use of clindamycin (627%), trimethoprim-sulfamethoxazole (380%), cephalosporins (160%), and amoxicillin-clavulanate (627%). Health care utilization and antibiotic prescribing rates for SSTI, but not incision-and-drainage procedures, have increased in association with the CA-MRSA epidemic. While much of the increase in antibiotic use reflects an appropriate change to trimethoprim-sulfamethoxazole, there is room for education regarding the limitations of cephalosporins and clindamycin, given current susceptibility profiles.
authors.affiliation: University of British Columbia, Vancouver, British Columbia, Canada. fawziah.marra@ubc.ca
authors.forename: Fawziah
authors.initials: F
authors.lastname: Marra
authors.forename: David M
authors.initials: DM
authors.lastname: Patrick
authors.forename: Mei
authors.initials: M
authors.lastname: Chong
authors.forename: Rachel
authors.initials: R
authors.lastname: McKay
authors.forename: Linda
authors.initials: L
authors.lastname: Hoang
authors.forename: William R
authors.initials: WR
authors.lastname: Bowie
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001955:British Columbia / Q000453:epidemiology; D016208:Databases, Factual; D004363:Drug Utilization / Q000706:statistics & numerical data / Q000639:trends*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009819:Office Visits / Q000706:statistics & numerical data; D011153:Population; D012874:Skin Diseases, Infectious / Q000188:drug therapy / Q000453:epidemiology* / Q000601:surgery; D018461:Soft Tissue Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000601:surgery; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents